Recent work suggests that the proteolytic degradation of the nuclear lamins is a common event in apoptosis, although the nature of the proteases involved is still not clear. Our previous work showed that the degradation of lamin B 1 in glucocorticoid-treated thymocytes occurs via a Ca 2؉ -sensitive mechanism and that exogenous Ca 2؉ promotes lamin degradation in isolated thymocyte nuclei from untreated cells. Here we demonstrate that peptide-based inhibitors of the interleukin 1-converting enzyme family of cysteine proteases (TyrVal-Ala-Asp fluoromethyl ketone) and of the nuclear scaffold multicatalytic proteinase (Ala-Pro-Phe chloromethyl ketone) block the degradation of lamin B 1 to a 21-kDa fragment in thymocytes treated with glucocorticoid, the Ca 2؉ -mobilizing agent thapsigargin, or antibodies to the T cell receptor. However, among a panel of inhibitors specific for several different proteases implicated in apoptosis, only tosylphenylalanyl chloromethyl ketone and the nuclear scaffold protease inhibitor block lamin degradation, histone H1 cleavage, and DNA fragmentation in isolated thymocyte nuclei incubated with Ca 2؉ . Overexpression of human BCL-2 in nuclei by stable transfection resulted in an inhibition of Ca 2؉ -stimulated lamin degradation and DNA fragmentation, suggesting that endogenous nuclear BCL-2 regulates activation of the nuclear scaffold protease. The results demonstrate the existence of an alternative pathway of lamin degradation and DNA fragmentation mediated by a resident Ca 2؉ -stimulated nuclear protease that is not directly dependent upon activation of the interleukin 1-converting enzyme family of cell death regulators.Apoptosis is a process of physiological cell death characterized by a series of stereotyped morphological alterations and endogenous endonuclease activation leading to the generation of large (50 kb 1 ) and oligonucleosomal DNA fragments (1, 2). Although inhibitors of macromolecular synthesis prevent apoptosis in many circumstances, it is currently thought that the essential enzymatic components of the effector pathway are constitutively expressed in all mammalian cells beyond the blastomere stage of embryonic development (3). The identities of these cell death mediators are currently not known, but a major recent breakthrough toward their identification has come from work on the genes that regulate programmed cell death in the nematode Caenorhabditis elegans (4). This work has revealed that the C. elegans death promoter ced-3 is structurally homologous to a growing family of proteins related to human interleukin 1-converting enzyme (ICE) (5), a cysteine protease. Subsequent research has shown that specific viral and peptide-based inhibitors of the ICE family block apoptotic cell death in many mammalian models (4 -9), indicating that ICE and its homologs play crucial roles in the effector phase of apoptosis.Recent work has shown that the nuclear lamins are cleaved by one or more members of the ICE family during apoptosis. Early work by Kaufmann (10) demonstrated th...